These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 20967847

  • 1. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
    Breckenridge LM, Bruns GL, Todd BL, Feuerstein M.
    Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
    [Abstract] [Full Text] [Related]

  • 2. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA.
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [Abstract] [Full Text] [Related]

  • 3. When breast cancer survivors report cognitive problems at work.
    Todd BL, Feuerstein EL, Feuerstein M.
    Int J Psychiatry Med; 2011 Oct; 42(3):279-94. PubMed ID: 22439297
    [Abstract] [Full Text] [Related]

  • 4. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U.
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [Abstract] [Full Text] [Related]

  • 5. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
    Von Ah D, Tallman EF.
    J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
    [Abstract] [Full Text] [Related]

  • 6. Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?
    Buwalda B, Schagen SB.
    Life Sci; 2013 Oct 17; 93(17):581-8. PubMed ID: 23353876
    [Abstract] [Full Text] [Related]

  • 7. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB.
    J Clin Oncol; 2012 Apr 01; 30(10):1080-6. PubMed ID: 22370315
    [Abstract] [Full Text] [Related]

  • 8. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK, Nielsen DL, Lindberg H, Kamby C.
    Ugeskr Laeger; 2007 Jan 22; 169(4):297-9. PubMed ID: 17274922
    [Abstract] [Full Text] [Related]

  • 9. Cognitive Deficits in Breast Cancer Survivors After Chemotherapy and Hormonal Therapy.
    Frank JS, Vance DE, Triebel KL, Meneses KM.
    J Neurosci Nurs; 2015 Dec 22; 47(6):302-12. PubMed ID: 26447567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Health-related quality of life in early breast cancer.
    Groenvold M.
    Dan Med Bull; 2010 Sep 22; 57(9):B4184. PubMed ID: 20816024
    [Abstract] [Full Text] [Related]

  • 12. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
    Schilder CM, Seynaeve C, Linn SC, Boogerd W, Beex LV, Gundy CM, Nortier JW, van de Velde CJ, van Dam FS, Schagen SB.
    Psychooncology; 2012 May 22; 21(5):479-87. PubMed ID: 21351188
    [Abstract] [Full Text] [Related]

  • 13. Adherence to long-term adjuvant hormonal therapy for breast cancer.
    Gotay C, Dunn J.
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec 22; 11(6):709-15. PubMed ID: 22098287
    [Abstract] [Full Text] [Related]

  • 14. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
    Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S.
    Psychooncology; 2009 Aug 22; 18(8):811-21. PubMed ID: 19085975
    [Abstract] [Full Text] [Related]

  • 15. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM, Eggens PC, Seynaeve C, Linn SC, Boogerd W, Gundy CM, Beex LV, Van Dam FS, Schagen SB.
    Acta Oncol; 2009 Aug 22; 48(1):76-85. PubMed ID: 18777410
    [Abstract] [Full Text] [Related]

  • 16. Advances in adjuvant hormonal therapy for postmenopausal women.
    Strasser-Weippl K, Goss PE.
    J Clin Oncol; 2005 Mar 10; 23(8):1751-9. PubMed ID: 15755983
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.